Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer’s disease biomarkers
Sophia Weiner(Institute of Neurobiology), Johan Gobom(Sahlgrenska University Hospital), Kaj Blennow(Sahlgrenska University Hospital), Pieter Jelle Visser, Betty M. Tijms(Amsterdam Neuroscience), Mathias Sauer(Sahlgrenska University Hospital), Henrik Zetterberg(Queen Mary University of London), Egor Vorontsov(University of Gothenburg)
Cited by 30
Related Papers
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k